1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsTrailblazer Award for Development of New Technologies for Early Detection of Cancer is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB). Supports the development of innovative technologies for early cancer detection.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Trailblazer R21 Awards | National Institute of Biomedical Imaging and Bioengineering Division of Applied Science & Technology (Biomedical Imaging) Program Area: Photoacoustic and Optoacoustic Technologies The Trailblazer R21 Award is an opportunity for New and Early Stage Investigators to pursue research programs of high interest to the NIBIB at the interface of the life sciences with engineering and the physical sciences.
The Trailblazer Notice of Funding Opportunity (NOFO), employs an R21 Exploratory/Developmental Research Grant mechanism, enhanced to provide $400,000 in direct costs over three years, allowing sufficient time and resources to pursue a new or emerging research program.
A Trailblazer project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. Importantly, applicants are expected to propose research approaches for which there are minimal or no preliminary data. Access the Trailblazer announcement .
To find out if you are eligible, see the NIH definition of New and Early Stage Investigators . For more information about the NIBIB R21 Trailblazer, see our Frequently Asked Questions .
According to the current listing, eligibility includes: Nonprofits, Universities, State/local governments, For-profit organizations. Confirm the full requirements in the official notice before applying.
The current listing shows up to $300,000 per year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Trailblazer Award for Development of New Technologies for Early Detection of Cancer is funded by National Institute of Biomedical Imaging and Bioengineering (NIBIB). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Small Business Innovation Research (SBIR)/ Small Business Technology Transfer... is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB). The NIBIB Small Business Program supports the translation of cutting-edge technologies into commercial products to address critical healthcare challenges. These programs encourage research and development with a strong potential for technology commercialization.
NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) is sponsored by National Institute of Biomedical Imaging and Bioengineering (NIBIB). NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices is a grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) that funds the translational development of innovative diagnostic and therapeutic medical devices.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe April 14 SBIR/STTR reauthorization restarted NIH's small-business pipeline after the shutdown, but the real signal is the sequencing of the new Small Business 101 webinars: program overview June 9, budget July 14, foreign risk August 18.
Read articleNIH's accelerating use of multiyear-funded grants — 601 awards worth $402 million in the first half of FY26, against just 146 awards worth $75 million in the same window of FY24 — has produced a fiscal contraction at research universities that has begun cascading into PhD admissions. AAU member institutions are admitting smaller graduate cohorts than they did in 2024 or 2025, with downstream consequences for the biomedical workforce, lab continuity, and the foreign-student pipeline through 2030. Why the contraction is structural rather than cyclical, and what universities, PIs, and prospective trainees should be doing in the second half of 2026.
Read article